Dinoprostone : interactions médicamenteuses

Dinoprostone (Cervidil, Prepidil, Prostin E2), analogue de prostaglandine, présente 36 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 3 de niveau majeur, 28 de niveau modéré, 5 de niveau mineur et 0 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.

Interactions d'après la notice

Interactions majeures (3)

  • …fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.8 , 5.9) ] • Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac sodium and misoprostol, other prostaglandins, or any components of the drug product [see Warnings and Precautions (5.8 , 5.10) ] • Pregnancy ( 4 ) (notice Diclofénac et misoprostol, Contre-indications)

  • KétorolacAINSMajeure

    Ketorolac tromethamine is contraindicated in labor and delivery because, through its prostaglandin synthesis inhibitory effect, it may adversely affect fetal circulation and inhibit uterine contractions, thus increasing the risk of uterine hemorrhage. (notice Kétorolac, Contre-indications)

  • Latanoprostanalogue de prostaglandineMajeure

    The combined use of two or more prostaglandins, or prostaglandin analogs including XELPROS is not recommended. (notice Latanoprost, Interactions médicamenteuses)

Interactions modérées (28)

  • Acide méfénamiqueAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Acide méfénamique, Mises en garde et précautions)

  • AténololbêtabloquantModérée

    Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (notice Aténolol, Interactions médicamenteuses)

  • Aténolol et chlortalidonebêtabloquantModérée

    Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (notice Aténolol et chlortalidone, Interactions médicamenteuses)

  • CélécoxibAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Célécoxib, Mises en garde et précautions)

  • DiclofénacAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Diclofénac, Mises en garde et précautions)

  • DiflunisalAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Diflunisal, Mises en garde)

  • ÉtodolacAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Étodolac, Mises en garde)

  • FénoprofèneAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Fénoprofène, Mises en garde et précautions)

  • FlurbiprofèneAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Flurbiprofène, Mises en garde et précautions)

  • Furosémidediurétique de l'anseModérée

    Indomethacin Coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis. (notice Furosémide, Interactions médicamenteuses)

  • Renal Toxicity and Hyperkalemia Renal Toxicity Long-term administration of NSAIDs has resulted in renal papillary necrosis and other renal injury.Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Hydrocodone et ibuprofène, Mises en garde)

  • IbuprofèneAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Ibuprofène, Mises en garde et précautions)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Ibuprofène et famotidine, Mises en garde et précautions)

  • IndométacineAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Indométacine, Mises en garde et précautions)

  • KétoprofèneAINSModérée

    A second form of renal toxicity has been seen in patients with conditions leading to a reduction in renal blood flow or blood volume, where renal prostaglandins have a supportive role in the maintenance of renal blood flow. (notice Kétoprofène, Mises en garde et précautions)

  • MéloxicamAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Méloxicam, Mises en garde et précautions)

  • Méthylergométrinealcaloïde de l'ergot de seigleModérée

    Caution should be exercised when methylergonovine maleate is used concurrently with other vasoconstrictors, ergot alkaloids, or prostaglandins. (notice Méthylergométrine, Interactions médicamenteuses)

  • NabumétoneAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Nabumétone, Mises en garde)

  • NaproxèneAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Naproxène, Mises en garde et précautions)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Naproxène et ésoméprazole, Mises en garde et précautions)

  • OxaprozineAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Oxaprozine, Mises en garde et précautions)

  • OxytocineModérée

    Prostaglandins, including CERVIDIL, may potentiate the effect of oxytocin [see Drug Interactions (7) ] . (notice Dinoprostone, Mises en garde et précautions)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Paracétamol et ibuprofène, Mises en garde et précautions)

  • PiroxicamAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Piroxicam, Mises en garde et précautions)

  • SalsalateAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Salsalate, Mises en garde)

  • SulindacAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion.In these patients, administration of a non-steroidal anti-inflammatory drug may cause a dose-dependent reduction in prostaglandin formation and, secondarily, in renal blood flow, which may precipitate overt renal decompensation. (notice Sulindac, Mises en garde)

  • Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Sumatriptan et naproxène, Mises en garde et précautions)

  • TolmétineAINSModérée

    Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (notice Tolmétine, Mises en garde)

Mentions mineures (5)

  • Carboprostanalogue de prostaglandineMineure

    Evidence from animal studies has suggested that certain other prostaglandins have some teratogenic potential. (notice Carboprost, Mises en garde)

  • Chlorure de potassiumsupplément de potassiumMineure

    Nonsteroidal Anti-inflammatory Drugs (NSAIDs) NSAIDs may produce potassium retention by reducing renal synthesis of prostaglandin E and impairing the renin-angiotensin system. (notice Chlorure de potassium, Interactions médicamenteuses)

  • ÉnoxaparineanticoagulantMineure

    Therapy consisting of prompt removal of the source of procoagulant material, replacement of depleted clotting factors and, in some cases, anti-coagulation with heparin should be instituted promptly. (notice Dinoprostone, Mises en garde et précautions)

  • HéparineanticoagulantMineure

    Therapy consisting of prompt removal of the source of procoagulant material, replacement of depleted clotting factors and, in some cases, anti-coagulation with heparin should be instituted promptly. (notice Dinoprostone, Mises en garde et précautions)

  • Tréprostinilanalogue de prostaglandineMineure

    Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (notice Tréprostinil, Mises en garde et précautions)

Vérifiez Dinoprostone avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.

Ouvrir dans le vérificateur

Ceci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.